SK15372003A3 - Nové kryštalické formy kyseliny 4-[4-[4-(hydroxydifenylmetyl)-1- piperidinyl]-1-hydroxybutyl]-alfa, alfa-dimetylbenzénoctovej a jej hydrochloridov - Google Patents
Nové kryštalické formy kyseliny 4-[4-[4-(hydroxydifenylmetyl)-1- piperidinyl]-1-hydroxybutyl]-alfa, alfa-dimetylbenzénoctovej a jej hydrochloridov Download PDFInfo
- Publication number
- SK15372003A3 SK15372003A3 SK1537-2003A SK15372003A SK15372003A3 SK 15372003 A3 SK15372003 A3 SK 15372003A3 SK 15372003 A SK15372003 A SK 15372003A SK 15372003 A3 SK15372003 A3 SK 15372003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- fexofenadine
- organic solvent
- hours
- reaction mixture
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN484MA2001 | 2001-06-18 | ||
| PCT/US2001/023994 WO2002102777A2 (fr) | 2001-06-18 | 2001-07-31 | Nouvelles formes cristallines d'acide 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a)-$g(a)- dimethylbenzene acetique et son chlorhydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK15372003A3 true SK15372003A3 (sk) | 2004-08-03 |
Family
ID=34566868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1537-2003A SK15372003A3 (sk) | 2001-06-18 | 2001-07-31 | Nové kryštalické formy kyseliny 4-[4-[4-(hydroxydifenylmetyl)-1- piperidinyl]-1-hydroxybutyl]-alfa, alfa-dimetylbenzénoctovej a jej hydrochloridov |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP2261209A1 (fr) |
| JP (2) | JP2005507374A (fr) |
| KR (1) | KR20040015734A (fr) |
| CN (1) | CN100390145C (fr) |
| AU (1) | AU2001278094B2 (fr) |
| BG (1) | BG108435A (fr) |
| BR (1) | BR0117054A (fr) |
| CA (2) | CA2450858C (fr) |
| CO (1) | CO5540340A2 (fr) |
| CZ (1) | CZ20033358A3 (fr) |
| EE (1) | EE200400010A (fr) |
| HU (1) | HUP0401546A2 (fr) |
| IL (2) | IL159266A0 (fr) |
| MX (1) | MXPA03011728A (fr) |
| NZ (1) | NZ530118A (fr) |
| PL (1) | PL367632A1 (fr) |
| RU (1) | RU2269516C2 (fr) |
| SK (1) | SK15372003A3 (fr) |
| WO (1) | WO2002102777A2 (fr) |
| ZA (1) | ZA200309557B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL366576A1 (en) * | 2001-04-09 | 2005-02-07 | Teva Pharmaceutical Industries Ltd. | Polymorphs of fexofenadine hydrochloride |
| US20040044038A1 (en) | 2002-06-10 | 2004-03-04 | Barnaba Krochmal | Polymorphic form XVI of fexofenadine hydrochloride |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| EP1628959A2 (fr) * | 2004-04-26 | 2006-03-01 | Teva Pharmaceutical Industries Ltd | Formes cristallines d'hydrochlorure de fexofenadine, et procedes pour les preparer |
| ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
| ITMI20041568A1 (it) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "polimorfi di fexofenadina base" |
| JP2008514641A (ja) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶形フェキソフェナジン、およびその調製方法 |
| WO2007007347A1 (fr) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Procédé industriel de préparation du chlorhydrate de fexofénadine avec un minimum de produits secondaires |
| EP2105134A1 (fr) | 2008-03-24 | 2009-09-30 | Ranbaxy Laboratories Limited | Hydrochlorure de fexofenadine amorphe stable |
| CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| JPH10500134A (ja) * | 1994-05-18 | 1998-01-06 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 抗ヒスタミン性ピペリジン誘導体の無水および水和形態、それらの多形態および擬似形態の製造方法 |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| IN191492B (fr) | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| GB0018691D0 (en) * | 2000-07-28 | 2000-09-20 | Rolabo Sl | Process |
-
2001
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/cs unknown
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/sk unknown
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/es active IP Right Grant
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/fr active IP Right Grant
- 2001-07-31 PL PL01367632A patent/PL367632A1/xx not_active Application Discontinuation
- 2001-07-31 EE EEP200400010A patent/EE200400010A/xx unknown
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/ko not_active Application Discontinuation
- 2001-07-31 CA CA002450858A patent/CA2450858C/fr not_active Expired - Fee Related
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/ja active Pending
- 2001-07-31 CA CA002646802A patent/CA2646802A1/fr not_active Abandoned
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
- 2001-07-31 EP EP10010066A patent/EP2261209A1/fr not_active Withdrawn
- 2001-07-31 EP EP01956057A patent/EP1399422A2/fr not_active Withdrawn
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/hu unknown
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/pt not_active Application Discontinuation
- 2001-07-31 IL IL15926601A patent/IL159266A0/xx unknown
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/ru not_active IP Right Cessation
- 2001-07-31 CN CNB018233791A patent/CN100390145C/zh not_active Expired - Fee Related
-
2003
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/xx unknown
- 2003-12-11 BG BG108435A patent/BG108435A/xx unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/es not_active Application Discontinuation
-
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20033358A3 (en) | 2004-04-14 |
| WO2002102777A8 (fr) | 2003-10-30 |
| CN1518540A (zh) | 2004-08-04 |
| BR0117054A (pt) | 2004-07-27 |
| CA2450858C (fr) | 2009-04-07 |
| JP2008094848A (ja) | 2008-04-24 |
| EP2261209A1 (fr) | 2010-12-15 |
| AU2001278094B2 (en) | 2006-01-12 |
| RU2004101045A (ru) | 2005-06-27 |
| RU2269516C2 (ru) | 2006-02-10 |
| IL159266A0 (en) | 2004-06-01 |
| CA2450858A1 (fr) | 2002-12-27 |
| WO2002102777A3 (fr) | 2003-02-27 |
| WO2002102777A2 (fr) | 2002-12-27 |
| MXPA03011728A (es) | 2004-07-08 |
| IL159266A (en) | 2010-11-30 |
| CN100390145C (zh) | 2008-05-28 |
| PL367632A1 (en) | 2005-03-07 |
| BG108435A (en) | 2004-12-30 |
| NZ530118A (en) | 2007-05-31 |
| EE200400010A (et) | 2004-02-16 |
| EP1399422A2 (fr) | 2004-03-24 |
| JP2005507374A (ja) | 2005-03-17 |
| KR20040015734A (ko) | 2004-02-19 |
| CA2646802A1 (fr) | 2002-12-27 |
| HUP0401546A2 (hu) | 2004-12-28 |
| ZA200309557B (en) | 2004-09-14 |
| CO5540340A2 (es) | 2005-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100174085A1 (en) | crystalline polymorphic forms of fexofenadine | |
| JP2008094848A (ja) | 新規な型の４−［４−［４−（ヒドロキシジフェニルメチル）−１−ピペリジニル］−１−ヒドロキシブチル］−α，α−ジメチルベンゼン酢酸及びその塩酸塩 | |
| BG61323B2 (bg) | Производни на пиперидина,тяхното получаване и използването им като лекарства | |
| US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
| MXPA03003459A (es) | Base venlafaxina cristalina y polimorfos novedosos de clorhidrato de venlafaxina, procesos para su preparacion. | |
| AU2001278094A1 (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride | |
| JP2011516519A (ja) | アルガトロバン一水和物の多形体及びその合成方法 | |
| US20060258705A1 (en) | Process for making crystalline donepezil hydrochloride monohydrate | |
| US6521758B2 (en) | Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols | |
| WO2007052310A2 (fr) | Polymorphes d'hydrochlorure de fexofenadine et processus de preparation de ceux-ci | |
| KR101125123B1 (ko) | 높은 광학적 순도의 ｓ-(-)-암로디핀을 제조하는 방법 및 그 중간생성 화합물 | |
| EP2072510A1 (fr) | Forme cristalline d'azélastine | |
| US5466826A (en) | Process for preparing a physical form of pharmaceutical agent | |
| US20060264637A1 (en) | Preparation of paroxetine hydrochloride hemihydrate | |
| EP2121643B1 (fr) | Nouveau procédé de préparation de la lévocétirizine et ses intermédiaires | |
| EP1975167A1 (fr) | Solvate d'acétone de phtaloyl amlodipine | |
| CA2525835C (fr) | Procede de cristallisation de toremifene | |
| WO2007110884A2 (fr) | Procede de preparation de chlorhydrate de fexofenadine anhydre tres pur | |
| KR20220127965A (ko) | 리나글립틴의 안정한 결정형 b의 제조방법 | |
| EP2154137A1 (fr) | Formule cristalline à base de moxifloxacine | |
| FR2800071A1 (fr) | Tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| WO2007131759A1 (fr) | Procédé de préparation de benzènesulfonate d'amlodipine | |
| JP2006525256A (ja) | 高純度ｒａｃ−１−｛４−［２−ヒドロキシ−３−（５−キノリルオキシ）プロピル］−ピペラジン−１−イル｝−２，２−ジフェニルエタン−１−オン・フマレートの製造方法及び高純度ｒａｃ−１−｛４−［２−ヒドロキシ−３−（５−キノリルオキシ）プロピル］−ピペラジン−１−イル｝−２，２−ジフェニルエタン−１−オン・フマレート |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB9A | Suspension of patent application procedure |